Bauyrzhan Aituov
Research Subjects
Bauyrzhan Aituov has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Arshat Urazbayev
PI National Laboratory Astana, Nazarbayev University, Astana, KAZAKHSTAN
1 shared publication - Askhat Myngbay
Department of Biology, K. Zhubanov Aktobe Regional University, Aktobe, Kazakhstan
1 shared publication - Bakhyt T. Matkarimov
National Laboratory Astana, Nazarbayev University, Astana 010000, Kazakhstan
1 shared publication - Yeldar Baiken
PI National Laboratory Astana, Nazarbayev University, Astana, KAZAKHSTAN
1 shared publication - Zamart Ramazanova
Department of Electrical and Computer Engineering, School of Engineering and Digital Sciences, Nazarbayev University, Astana 010000, Kazakhstan
1 shared publication
Latest Publications
- Open Access
- 30 October 2025
- Published by Astana IT University in Scientific Journal of Astana IT University
AN INFORMATION TECHNOLOGY APPROACH TO PREDICT BREAST CANCER USING MACHINE LEARNING
Breast cancer continues to be the most encountered malignancy in women globally and a leading cause of cancer-related mortality. This study describes an Information Technology approach to evaluate interpretable machine-learning methods for breast cancer prediction using routine clinical data and to situate performance against prior literature. All calculations are based on the Breast Cancer Wisconsin Diagnostic dataset (569 instances; malignant/benign labels) hosted by the UCI Machine Learning Repository. Each sample corresponds to a breast mass classified as malignant or benign. Four supervised machine learning models were applied: Logistic Regression with L1 penalty, Random Forest, Decision Tree, and Naïve Bayes, and compared the area under the ROC curve (AUC), accuracy, sensitivity, and specificity using DeLong’s test with Holm correction. The reproducible pipeline consisted of preprocessing, recursive feature elimination for feature selection, and a 5-fold cross-validation for hyperparameter tuning. Among the four models, the L1-penalized Logistic Regression yielded the best results, with an AUC indicating accuracy, sensitivity, and specificity of 99.6% (97.3%, 95.2%, 98.6%) on the test sets, respectively. This study illustrates the effective integration of supervised machine learning methods into diagnostic systems to produce early, accurate, interpretable diagnoses of disease. This study reinforces the proposed information technology approach for breast cancer prognosis. Limitations of the study are a moderately sized, homogeneous cohort, and restricted focus on structured variables, which may enhance internal validity while restricting generalizability. Our findings contribute to an emerging body of literature that well-tuned, regularized logistic regression provides a reasonable baseline against which breast cancer risk and other study outcomes can be compared, and a pragmatic route toward trustworthy AI in oncology.
- 30 October 2025
- Published by Astana IT University in Scientific Journal of Astana IT University
Open AccessAN INFORMATION TECHNOLOGY APPROACH TO PREDICT BREAST CANCER USING MACHINE LEARNING
Breast cancer continues to be the most encountered malignancy in women globally and a leading cause of cancer-related mortality. This study describes an Information Technology approach to evaluate interpretable machine-learning methods for breast cancer prediction using routine clinical data and to situate performance against prior literature. All calculations are based on the Breast Cancer Wisconsin Diagnostic dataset (569 instances; malignant/benign labels) hosted by the UCI Machine Learning Repository. Each sample corresponds to a breast mass classified as malignant or benign. Four supervised machine learning models were applied: Logistic Regression with L1 penalty, Random Forest, Decision Tree, and Naïve Bayes, and compared the area under the ROC curve (AUC), accuracy, sensitivity, and specificity using DeLong’s test with Holm correction. The reproducible pipeline consisted of preprocessing, recursive feature elimination for feature selection, and a 5-fold cross-validation for hyperparameter tuning. Among the four models, the L1-penalized Logistic Regression yielded the best results, with an AUC indicating accuracy, sensitivity, and specificity of 99.6% (97.3%, 95.2%, 98.6%) on the test sets, respectively. This study illustrates the effective integration of supervised machine learning methods into diagnostic systems to produce early, accurate, interpretable diagnoses of disease. This study reinforces the proposed information technology approach for breast cancer prognosis. Limitations of the study are a moderately sized, homogeneous cohort, and restricted focus on structured variables, which may enhance internal validity while restricting generalizability. Our findings contribute to an emerging body of literature that well-tuned, regularized logistic regression provides a reasonable baseline against which breast cancer risk and other study outcomes can be compared, and a pragmatic route toward trustworthy AI in oncology.